ADMS

Adamas Pharmaceuticals, Inc.
ADMS

Overview Fund Activity
Delisted

ADMS was delisted on the 23rd of November, 2021.

Back to rankings

93 hedge funds and large institutions have $316M invested in Adamas Pharmaceuticals, Inc. in 2015 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 28 increasing their positions, 25 reducing their positions, and 15 closing their positions.

Holders
93
Holders Change
+10
Holders Change %
+12.05%
% of All Funds
2.44%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
25
Increased
28
Reduced
25
Closed
15
Calls
$831K
Puts
$104K
Net Calls
+$727K
Net Calls Change
+$727K

Top Buyers

1
GPP
1
Great Point Partners
Connecticut
$40.7M
2
Millennium Management
2
Millennium Management
New York
$10.6M
3
BFA
3
BlackRock Fund Advisors
California
$13.9M
4
Citadel Advisors
4
Citadel Advisors
Florida
$6.5M
5
SFM
5
Sphera Funds Management
Israel
$4.25M

Top Sellers

1
CPH
1
C Partners Holding
Switzerland
$23.7M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$4.81M
3
WSA
3
Wall Street Associates
California
$3.54M
4
TC
4
TFS Capital
Pennsylvania
$1.72M
5
Deutsche Bank
5
Deutsche Bank
Germany
$177K
Name Holding Trade Value Shares
Change 		Shares
Change %
TI
101
Trexquant Investment
Connecticut
– -$194K -11,600 Closed
MLICM
102
Metropolitan Life Insurance Company (MetLife)
New York
– -$133K -7,926 Closed
FCE
103
Fiera Capital (Europe)
Cayman Islands
– -$114K -6,812 Closed
TRCT
104
Tower Research Capital (TRC)
New York
– -$48K -2,838 Closed
US Bancorp
105
US Bancorp
Minnesota
– -$41K -2,465 Closed
BJ
106
BlackRock Japan
Japan
– -$5K -326 Closed
Federated Hermes
107
Federated Hermes
Pennsylvania
– -$1K -85 Closed
1 2 3 4
5